Assessing a multicomponent quality improvement strategy for chronic care of cardiovascular diseases in India: The C-QIP randomized feasibility trial
PLOS Medicine · 2026
DOI: 10.1371/journal.pmed.1004932 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift PLOS Medicine, 2026. Verfasst von Kavita Singh und 20 weiteren Autor:innen. Beteiligte Einrichtung: Heidelberg Institute of Global Health, Heidelberg University, Heidelberg, Germany. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Quality Improvement. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, FIC NIH HHS, Fogarty International Center.
Abstract (Originalsprache)
Background
Chronic cardiovascular diseases (CVD) care quality remains suboptimal, globally. We assessed the feasibility, acceptability, fidelity, and preliminary effect of a multicomponent, collaborative quality improvement (C-QIP) strategy among patients with CVD attending outpatient clinics in India. Methods and findings In this pragmatic feasibility randomized controlled trial, 410 adults with ischemic heart disease, ischemic stroke, or heart failure attending four public and private hospitals were randomized to C-QIP (electronic decision support for providers, non-physician care coordination, patient education, text-message reminders, and audit-feedback) or usual care. Primary outcomes were feasibility, fidelity, adoption, and acceptability; secondary outcomes included guideline-directed medical therapy (GDMT), self-reported adherence, care processes, and risk factors. At end of study (median follow-up 15 months), retention was 192/206 (93.2%) in C-QIP and 187/204 (91.7%) in usual care. Fidelity was high: 187/198 (94.4%) C-QIP participants received lifestyle counseling at end of study. C-QIP increased GDMT use for ischemic heart disease (58.3% versus 32.4%; relative risk [RR] 1.45, 95% CI [1.18, 1.78]) and ischemic stroke (76.7% versus 31.8%; RR 2.41, 95% CI [1.52, 3.81]), but not heart failure. Self-reported adherence was higher for medications (90.9% versus 82.3%; RR 1.08, 95% CI [1.04, 1.12]), diet (91.9% versus 82.3%; RR 1.07, 95% CI [1.02, 1.13]), and physical activity (91.4% versus 70.4%; RR 1.23, 95% CI [1.16, 1.30]). Limitations include feasibility design, individual randomization within shared clinics, and limited power for clinical outcomes and subgroup analysis.
Conclusions
The C-QIP trial demonstrated that a multicomponent strategy is feasible, acceptable, and improved chronic CVD care processes in India. Future large, confirmatory hybrid trials are needed to establish whether such quality improvement strategies can reduce cardiovascular morbidity and mortality. Trial Registrations NCT05196659 ; CTRI/2022/04/041847
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Heidelberg Institute of Global Health, Heidelberg University, Heidelberg, Germany.
- Public Health Foundation of India, New Delhi, India.
- Centre for Chronic Disease Control, New Delhi, India.
- All India Institute of Medical Sciences, New Delhi, India.
- SDM College of Medical Sciences and Hospital, Shri Dharmasthala Manjunatheshwara University, Dharwad, Karnataka, India.
- GB Pant Hospital, New Delhi, India.
ORCID-Profile: Kavita Singh, Ambuj Roy, Dimple Kondal, Kalyani Nikhare, Satish G Patil, Kiran Aithal, Meenahalli Palleda Girish, Mohit Gupta, Kushal Madan, Kamar Ali, Meetushi Jain, Savitesh Kushwaha, Emily Mendenhall, Shivani A Patel, Kabayam M Venkat Narayan, Nikhil Tandon, Mark D Huffman, Dorairaj Prabhakaran
Förderung
- NHLBI NIH HHS
- FIC NIH HHS
- Fogarty International Center
- National Institutes of Health
Zitieren
APA
Singh, K., Roy, A., Kondal, D., Nikhare, K., Gandral, M., Patil, S. G., Aithal, K., Girish, M. P., Gupta, M., Madan, K., Sawhney, J. P. S., Ali, K., Jain, M., Kushwaha, S., Jindal, D., Mendenhall, E., Patel, S. A., Narayan, K. M. V., Tandon, N., …, & Prabhakaran, D. (2026). Assessing a multicomponent quality improvement strategy for chronic care of cardiovascular diseases in India: The C-QIP randomized feasibility trial. PLOS Medicine. https://doi.org/10.1371/journal.pmed.1004932
Vancouver
Singh K, Roy A, Kondal D, Nikhare K, Gandral M, Patil SG, et al. Assessing a multicomponent quality improvement strategy for chronic care of cardiovascular diseases in India: The C-QIP randomized feasibility trial. PLOS Medicine. 2026. doi:10.1371/journal.pmed.1004932
BibTeX
@article{Singh2026,
author = {Singh, Kavita and Roy, Ambuj and Kondal, Dimple and Nikhare, Kalyani and Gandral, Mareesha and Patil, Satish G and Aithal, Kiran and Girish, Meenahalli Palleda and Gupta, Mohit and Madan, Kushal and Sawhney, Jitendra P S and Ali, Kamar and Jain, Meetushi and Kushwaha, Savitesh and Jindal, Devraj and Mendenhall, Emily and Patel, Shivani A and Narayan, Kabayam M Venkat and Tandon, Nikhil and Huffman, Mark D and Prabhakaran, Dorairaj},
title = {Assessing a multicomponent quality improvement strategy for chronic care of cardiovascular diseases in India: The C-QIP randomized feasibility trial},
journal = {PLOS Medicine},
year = {2026},
doi = {10.1371/journal.pmed.1004932}
}
EUVIMED